Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Selectis Health (GBCS) Receivables - Other (2017 - 2024)

Selectis Health's Receivables - Other history spans 10 years, with the latest figure at $711634.0 for Q4 2024.

  • For Q4 2024, Receivables - Other fell 13.23% year-over-year to $711634.0; the TTM value through Dec 2024 reached $711634.0, down 13.23%, while the annual FY2024 figure was $711634.0, 13.23% down from the prior year.
  • Receivables - Other for Q4 2024 was $711634.0 at Selectis Health, down from $820124.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $996400.0 in Q4 2022 and bottomed at $410866.0 in Q4 2020.
  • The 5-year median for Receivables - Other is $820124.0 (2023), against an average of $758536.0.
  • The largest annual shift saw Receivables - Other surged 107.77% in 2021 before it decreased 17.69% in 2023.
  • A 5-year view of Receivables - Other shows it stood at $410866.0 in 2020, then soared by 107.77% to $853656.0 in 2021, then rose by 16.72% to $996400.0 in 2022, then decreased by 17.69% to $820124.0 in 2023, then dropped by 13.23% to $711634.0 in 2024.
  • Per Business Quant, the three most recent readings for GBCS's Receivables - Other are $711634.0 (Q4 2024), $820124.0 (Q4 2023), and $996400.0 (Q4 2022).